EpicentRx, Inc.   Report issue

For profit Phase 1 Phase 2 Phase 3
Founded: Mountain View CA United States (2002)

Organization Overview

First Clinical Trial
2011
NCT01359982
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

EpicentRx, Inc.